NCT01236885

Computer-Guided Glucose Management Systems in Treating Patients With Hyperglycemia Who Have Undergone Blood and Bone Marrow Transplant

Use of a Computer-Guided Glucose Management System for Patients Undergoing Blood and Marrow Transplants (BMT)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 19 (actual)
• Sponsor: Fred Hutchinson Cancer Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This clinical trial studies computer-guided glucose management systems in treating patients with hyperglycemia who have undergone blood and bone marrow transplant. A computer-guided glucose management system may help manage glucose levels in patients who have undergone blood or bone marrow transplant.

Detailed description

PRIMARY OBJECTIVES: I. To examine the ability of computer-guided glucose management system (CGGMS) algorithms to control glucose within or close to current University of Washington Medical Center (UWMC) intensive care unit (ICU) targets (100 to 140 mg/dl) in non-critically ill bone marrow transplant (BMT) adult (age \>= 18 years) patients. OUTLINE: Patients receive blood glucose management with intravenous (IV) insulin using Glucommander.

Conditions

• Hyperglycemia
• Malignant Neoplasm

Interventions

Type	Name	Description
OTHER	computer-assisted intervention	Undergo blood glucose management using Glucommander

Timeline

• Start date: 2012-12-01
• Primary completion: 2015-02-01
• First posted: 2010-11-09
• Last updated: 2015-04-23

Locations

2 sites across 1 country: United States